Alert: Packaging World now enhanced for the iPad and iPhone. Watch a quick video preview
Download Download this free, 150-page Pharmaceutical Serialization Playbook jam-packed with strategies for success and pitfalls to avoid.  Learn more >>
Article |

Healthy developments stirring in pharmaceutical contract manufacturing

Cel-Sci, Genzyme, and Pfizer announce contract manufacturing, outsourcing plans for drug and biopharmaceutical products.
Print Reprint
FILED IN:  Package Feature  > Shelf life  > Aseptic

Recent reports from in-Pharma illustrate that production within the life science industry is off to an impressive start in this new year.

For example, the Web site reports that Cel-Sci has validated production equipment at its Baltimore, MD, GMP facility for aseptic filling and is ready to commence manufacture of its cancer drug Multikine. Once Cel-Sci has produced enough material for a Phase III trial of the drug, it says it will offer contract manufacturing services from the facility.

Earlier, in-Pharma noted that Genzyme was “outsourcing the fill and finish manufacturing of several major drugs to Hospira in response to in-house difficulties at its Allston Landing facility in Boston.”

Meanwhile, “Pfizer will soon sell more generic pharmaceuticals in the U.S. after its agreement with Indian non-branded drugmaker Strides Arcolab,” according to in-Pharma

These developments provide a beacon of hope for 2010.


Add new comment

42 Best Package Designs
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!


Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
Each newsletter ranges in frequency from once per month to a few times per month at most.